EBAG9 and neoplasm: To investigate if expression of endogenous EBAG9 correlates with the occurrence of the 22-1-1 antigen, we have chosen several tumor cell lines and examined their EBAG9 protein content by immunoblot, whereas 22-1-1 surface staining was assessed by flow cytometry.